Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
Phase 3
Active, not recruiting
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Drug: Atezolizumab(Tecentriq)Drug: PemetrexedDrug: Carboplatin or cisplatinDrug: BevacizumabDrug: CarboplatinDrug: Paclitaxel
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 228
- Registration Number
- NCT03991403
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnamgu, Korea, Republic of
Neoadjuvant Nivolumab for Operable Esophageal Carcinoma
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03987815
- Locations
- 🇰🇷
Jong-Mu Sun, Seoul, Korea, Republic of
Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression
- Conditions
- Lymphoma, Large B-Cell, Diffuse
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT03977623
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean Population.
Completed
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- First Posted Date
- 2019-06-05
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT03974971
- Locations
- 🇰🇷
Samsung medical center, Seoul, Gang Nam, Korea, Republic of
Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Procedure: Frozen section biopsy for margin statusProcedure: Omission of intraoperative frozen section biopsy for margin status
- First Posted Date
- 2019-06-05
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1292
- Registration Number
- NCT03975179
- Locations
- 🇰🇷
Ilsan Paik Hospital, Goyang-si, Korea, Republic of
🇰🇷Seoul St. Mary's Hospital, Seoul, Korea, Republic of
Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction
Not Applicable
Completed
- Conditions
- Meibomian Gland Dysfunction
- Interventions
- Device: Intense Pulsed Light (IPL)
- First Posted Date
- 2019-05-15
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 81
- Registration Number
- NCT03950115
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Atrial Sensing Capability for Better Detection of Atrial Fibrillation
Not Applicable
- Conditions
- Cardiac ArrhythmiaImplantable Cardioverter DefibrillatorAtrial FibrillationCardiac Event
- Interventions
- Device: Atrial sensing On mode
- First Posted Date
- 2019-05-01
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 640
- Registration Number
- NCT03932604
- Locations
- 🇰🇷
Daegu Catholic University Medical Center, Daegu, Korea, Republic of
🇰🇷National Health Insurance Service Ilsan Hospital, Goyang, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery
Phase 1
- Conditions
- HER2-positive Breast Cancer
- Interventions
- Drug: TAHP and AHPDrug: TAHP plus AC and AHP
- First Posted Date
- 2019-03-20
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT03881878
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effects of Hippotherapy on Physical Fitness and Attention in Cerebral Palsy
Not Applicable
Completed
- Conditions
- Attention DisorderPhysical ActivityCerebral Palsy
- Interventions
- Behavioral: hippotherapy
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 47
- Registration Number
- NCT03870893
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Long-term Outcomes and Prognostic Factors in Patient Undergoing CABG or PCI
Recruiting
- Conditions
- Ischemic Heart Disease
- Interventions
- Procedure: PCIProcedure: CABG
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10000
- Registration Number
- NCT03870815
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath